Diabetic ketoacidosis, or DKA, is an acute metabolic emergency. It develops when the body has too little effective insulin to control fat breakdown. The liver converts fatty acids into ketones faster than tissues and kidneys can use or clear them. Ketones are acids; as they accumulate, blood chemistry becomes dangerously acidic.
High glucose pulls water and electrolytes into the urine, producing dehydration. Stress hormones drive glucose and ketones higher. Potassium shifts out of cells even while total body potassium is being lost. The combination can impair circulation, breathing, consciousness, and heart rhythm. DKA cannot be reduced to “high sugar,” and a normal-looking glucose value does not always exclude it.
Insulin normally restrains ketone production#
Insulin does more than lower glucose. It signals that energy is available and suppresses release of fatty acids from adipose tissue; when insulin is absent or severely insufficient, glucagon, catecholamines, cortisol, and growth hormone promote fat breakdown. The liver turns the incoming fatty acids into beta-hydroxybutyrate and acetoacetate.
Small ketone production can occur during ordinary fasting. DKA is different in scale and context. Ketone generation is unrestrained, bicarbonate is consumed buffering acid, and pH falls. Hyperglycemia produces osmotic diuresis. So water, sodium, and potassium are lost. So are phosphate and other solutes.
Measured serum potassium may initially be normal or high because acidosis and insulin deficiency move potassium out of cells. Total body stores are nevertheless depleted. Once fluid and insulin treatment begins, potassium shifts back into cells and the measured level can fall quickly. That is why repeated laboratory monitoring is central to treatment.
The 2024 adult consensus uses three diagnostic components#
The international 2024 consensus defines adult DKA through three elements. First is diabetes or hyperglycemia: glucose at least 200 mg/dL or a prior history of diabetes. Second is ketosis: beta-hydroxybutyrate at least 3.0 mmol/L or, when blood testing is unavailable, urine ketones at least 2+. Third is acidosis: venous pH below 7.3, bicarbonate below 18 mmol/L, or both.
The glucose threshold was lowered from older criteria because a meaningful minority of episodes are euglycemic. The diagnosis therefore rests on the triad, not a dramatic glucose cutoff. Clinicians also assess severity, mental status, and osmolality. They assess kidney function, potassium, and the suspected precipitant.
The anion gap often rises as unmeasured ketoacids accumulate, but the consensus does not require it as the primary diagnostic or resolution measure when direct beta-hydroxybutyrate testing is available; vomiting, kidney dysfunction, chloride-rich fluids, and mixed acid-base disturbances can complicate its interpretation.
Symptoms reflect dehydration and acidosis#
Early symptoms can include thirst, frequent urination, fatigue, dry mouth, and rising glucose or ketones. Nausea, vomiting, and abdominal pain commonly follow. Breathing may become deep and rapid as the lungs try to reduce carbon dioxide and compensate for acidosis. Breath can have a fruity odor, but its absence proves nothing.
Progressive dehydration can produce a fast pulse, low blood pressure, weakness, and reduced urine. Confusion, marked drowsiness, or loss of consciousness indicates severe illness. Children and adolescents can deteriorate rapidly and have a distinct cerebral-injury risk requiring pediatric protocols.
No symptom list is perfectly specific. Gastroenteritis can cause vomiting in a person with diabetes and also trigger DKA. Abdominal pain can improve as acidosis resolves, but persistent focal pain can indicate a surgical condition. When insulin deficiency is possible, symptoms and ketone results should be interpreted together.
Type 1 diabetes has the clearest biological vulnerability#
People with type 1 diabetes depend on administered insulin. A missed basal dose, an empty or spoiled insulin supply, or infusion-set blockage can begin ketogenesis within hours. So can a dislodged cannula, pump failure, or interruption caused by cost. Illness raises insulin requirements even when little food is eaten.
DKA may be the first presentation of type 1 diabetes. New thirst, urination, and weight loss should not be attributed only to a viral illness. Neither should fatigue or worsening vomiting. Adults can also develop autoimmune diabetes and may initially be classified as type 2.
People with type 2 diabetes can develop DKA during severe infection, myocardial infarction, or stroke. They can develop it during pancreatitis, glucocorticoid use, insulin deficiency, or other stress. Ketosis-prone diabetes can present with DKA in a person who later recovers enough beta-cell function to reduce insulin, but that classification requires follow-up rather than assumptions during the emergency.
SGLT2 inhibitors change the glucose signal#
SGLT2 inhibitors cause glucose to leave through urine. They can reduce blood glucose while insulin is insufficient and ketone production rises. DKA associated with this class may therefore present with glucose below traditional expectations.
Risk factors include acute illness, surgery, and prolonged fasting. They include dehydration, reduced insulin, and very-low-carbohydrate eating. They also include excessive alcohol and pancreatic insulin deficiency. Symptoms such as nausea, abdominal pain, malaise, or rapid breathing deserve ketone assessment even if a meter value is not striking.
Current guidance includes holding SGLT2 inhibitors before scheduled surgery and during critical illness or prolonged fasting. Exact timing and restart criteria depend on the product and situation. Ask for that plan in writing rather than work the rule out once symptoms have started. SGLT2 inhibitors are not FDA-approved for type 1 diabetes.
Pregnancy requires a lower threshold for concern#
Pregnancy increases susceptibility to ketosis because of hormonal insulin resistance, accelerated starvation physiology, and increased energy demands, and DKA can occur at lower glucose here while posing risk to both pregnant patient and fetus. Persistent vomiting, inability to keep down carbohydrate or fluid, illness, or ketones requires prompt obstetric and diabetes guidance.
Hyperemesis, infection, glucocorticoids, pump problems, and missed insulin can precipitate episodes. Fetal distress can improve when maternal circulation and acidosis are corrected, so treatment focuses on the mother's metabolic emergency while obstetric monitoring is tailored to gestational age and severity.
General adult home advice should not be copied into pregnancy without an individualized plan. Ketone targets, insulin adjustments, and escalation thresholds can differ.
Blood beta-hydroxybutyrate is the preferred ketone measure#
Beta-hydroxybutyrate is the predominant ketone in DKA. Point-of-care or laboratory blood measurement gives a quantitative value and responds more directly to treatment. Urine strips mainly detect acetoacetate. Early in DKA they can underestimate severity because beta-hydroxybutyrate predominates; during recovery they can remain positive as beta-hydroxybutyrate converts back to acetoacetate.
Urine testing remains useful when blood testing is not available, but a negative or modest result should not overrule concerning symptoms. Expiration dates, storage, strip technique, and color-reading time affect accuracy. If you are at risk, know which meter or strips you are meant to use and what result triggers a call or an emergency visit.
Breath acetone devices are not the standard for diagnosing or managing DKA. Consumer products marketed for nutritional ketosis may not be validated for diabetic emergencies.
Sick-day care aims to interrupt the process early#
A sick-day plan tells you how often to check glucose and ketones, how to keep fluid and carbohydrate going in, which medicines to hold, how to give correction insulin, and when to contact your team. It should distinguish type 1 from type 2 diabetes and account for pumps, pregnancy, kidney disease, and SGLT2 inhibitors.
People with type 1 diabetes generally must not stop basal insulin, even when not eating. The dose may need adjustment, and extra rapid-acting insulin may be required for ketones under professional guidance. Repeated vomiting makes oral hydration and home correction unreliable.
Fluids with and without carbohydrate may be alternated depending on glucose and insulin needs, and a generic instruction to drink unlimited water can be unsafe for someone with heart or kidney failure, so the plan should name practical quantities rather than leave you to estimate them while ill. It should also carry emergency numbers and the nearest appropriate facility. Write those down early.
When home management has reached its limit#
Emergency assessment is appropriate if you have persistent moderate or high ketones, blood beta-hydroxybutyrate at a concerning threshold under your care plan, repeated vomiting, inability to keep fluid down, deep rapid breathing, confusion, severe abdominal pain, dehydration, or glucose and ketones that fail to improve after directed correction.
Someone who is drowsy, confused, faint, breathing abnormally, or unable to self-manage should not drive. Emergency services can begin assessment and transport safely. DKA can coexist with sepsis, heart attack, stroke, or another time-sensitive illness.
Telephone advice is not a substitute for laboratory measurement when acidosis may be present. Home ketone reduction can be reassuring only when the person is clinically well and following a plan designed for that situation.
Hospital treatment coordinates several moving targets#
Initial treatment restores circulating volume with intravenous fluid. The fluid type and rate depend on blood pressure, sodium, and kidney and heart status. They also depend on age and dehydration. Insulin stops lipolysis and ketone production. When glucose falls before ketoacidosis has resolved, dextrose is added so insulin can continue safely until ketones and acidosis clear.
Potassium guides insulin timing and replacement. If potassium is dangerously low, insulin may be delayed while potassium is replaced because insulin could provoke an arrhythmia-producing fall. Sodium, phosphate, and magnesium are followed according to severity and protocol. So are glucose, venous pH, bicarbonate, and beta-hydroxybutyrate.
Routine bicarbonate is not recommended for most DKA because fluid and insulin correct the underlying process, and bicarbonate can create harms. It may be considered in extreme acidosis under specialist management. Phosphate is not replaced routinely unless clinically important depletion or related complications are present.
Resolution is not simply a normal glucose value#
Glucose often improves before ketoacidosis. Stopping intravenous insulin when a meter reaches a target can allow ketone production to rebound. The 2024 consensus defines resolution using ketone and acid-base improvement, not glucose alone.
Transition to subcutaneous insulin requires overlap so that circulating insulin does not disappear between the infusion and the next dose. The regimen should account for prior treatment, nutrition, kidney function, and the trigger. A person with newly diagnosed diabetes needs education and supplies before discharge.
The precipitating cause must also be treated. Antibiotics are used for confirmed or strongly suspected infection, not automatically for DKA itself. Cardiac, pancreatic, medication, pregnancy, and access-related triggers each require different action.
Prevention after discharge is a system responsibility#
Recurrent DKA often reflects more than knowledge. Insulin cost, unstable housing, and depression can make prevention instructions impossible. So can disordered eating, substance use, and fear of hypoglycemia. So can fragmented care and device supply gaps. A discharge plan should solve access before the last hospital dose wears off.
You should leave with basal and mealtime insulin if they are prescribed, the supplies to give them, glucose and ketone testing, glucagon, written dose and sick-day instructions, and timely follow-up. Pump users need backup long-acting and rapid-acting injection plans appropriate to their device and doses.
A nonjudgmental review asks exactly what happened before the episode. If an infusion set failed, improve troubleshooting and alert settings. If insulin was rationed, address coverage and supply. If vomiting caused uncertainty, rewrite the sick-day algorithm. Prevention is strongest when the plan fits the actual failure point.
References#
- 2024 international consensus report on hyperglycemic crises
- ADA Standards of Care 2026, glycemic goals and hyperglycemic crises
- ADA Standards of Care 2026, diabetes care in the hospital
- FDA-approved empagliflozin prescribing information: ketoacidosis warning
- ISPAD pediatric DKA and hyperosmolar-state guideline
- CDC overview of diabetic ketoacidosis
Suspected DKA is an emergency; use the person's sick-day plan and seek urgent medical assessment rather than relying on this article.*
Questions and answers
What causes diabetic ketoacidosis?
Too little effective insulin allows rapid fat breakdown and ketone production. Stress hormones worsen glucose and dehydration. Infection, missed insulin, pump failure, new diabetes, acute illness, pregnancy, and SGLT2 inhibitors are among common triggers.
Can DKA occur when glucose is below 250 mg/dL?
Yes. Euglycemic DKA can occur with SGLT2 inhibitors, pregnancy, fasting, reduced carbohydrate intake, alcohol, or partial insulin treatment. Symptoms, beta-hydroxybutyrate, and acid-base testing matter more than an old glucose cutoff.
Are urine ketone strips enough to rule out DKA?
No. They detect acetoacetate and can lag behind beta-hydroxybutyrate, the predominant ketone in DKA. Blood ketones and laboratory acid-base assessment are more direct when symptoms or risk are concerning.
Should basal insulin be stopped when someone cannot eat?
People with type 1 diabetes and others with severe insulin deficiency generally continue basal insulin to prevent ketogenesis, although dose, carbohydrate, and fluids may need adjustment. Follow an individualized sick-day plan and seek urgent help for vomiting or rising ketones.
How is DKA treated in the hospital?
Treatment replaces fluid, gives insulin to stop ketone production, monitors and replaces potassium and other electrolytes, adds dextrose when needed to continue insulin safely, confirms resolution of acidosis, and treats the trigger.